Animal parasiticides market was valued at $12.9 billion in 2025 and is projected to reach $26.4 billion by 2035, growing at a CAGR of 7.5% during the forecast Period (2026-2035). Expanding regulatory approvals for advanced parasiticides are boosting global availability and adoption, thereby significantly driving market growth in both developed and emerging economies. This trend is exemplified by recent approvals of long-acting injectable and multi-target parasiticides, which provide enhanced convenience and broader parasite control for companion animals. For instance, in July 2025, the FDA approved BRAVECTO QUANTUM (fluralaner for extended-release injectable suspension), a once-yearly injectable for treating and preventing flea and tick infestations in dogs. It will be available at veterinary clinics by August 2025.

AI data center market was valued at $168 billion in 2025 and is projected to reach $505.1 billion by 2035, growing at a CAGR of 11.8% during the forecast Period (2026-2035). Rising demand for AI capabilities is driving enterprises and governments to prioritize AI integration, fueling the growth of scalable, high-performance data center infrastructure. This trend is reflected in significant investments in AI-ready facilities designed to handle large-scale AI workloads efficiently. New multi-gigawatt data centers are being developed across key regions, with projects focusing on affordability, energy efficiency, and advanced computing capabilities to support nationwide AI adoption. These developments are expected to strengthen the overall AI data center market and accelerate its expansion. For instance, in February 2026, Reliance Industries Ltd. invested $110 billion in Indian data centers and infrastructure over seven years. 

Acetaldehyde market was valued at $1.4 billion in 2025 and is projected to reach $2.6 billion by 2035, growing at a CAGR of 3.5% during the forecast Period (2026-2035). Significant investments in new acetaldehyde facilities are increasing global production capacity to meet rising demand from downstream industries, thereby driving market growth. These investments reflect the broader trend of strategic capacity expansion in key regions to strengthen supply chains, support growing industrial and pharmaceutical consumption, and incorporate advanced technologies for improved efficiency and sustainability.

3D IC design and manufacturers software market was valued at $12.6 billion in 2025 and is projected to reach $32.6 billion by 2035, growing at a CAGR of 10.0% during the forecast Period (2026-2035). Expansion in industrial, automotive, and high-performance computing sectors is driving demand for specialized design and analysis software for 3D ICs. Increasing complexity in multi-die and stacked architectures, combined with stringent performance, power, and reliability requirements, is encouraging manufacturers to adopt advanced design and verification solutions that streamline workflows, optimize chip performance, and reduce risks. For instance, in June 2025, Siemens introduced the Innovator3D IC suite, which streamlines the design and analysis of complex, heterogeneously integrated 2.5D and 3D Integrated Circuits (ICs). 

Asia-Pacific wound dressing market was valued at $4335.0 million in 2025 and is projected to reach $ 7068.6 million by 2035, growing at a CAGR of 4.6% during the forecast Period (2026-2035). Diabetic foot ulcers (DFUs) play a critical role in driving the Asia?Pacific wound dressing market. The rising prevalence of diabetes in countries such as India, China, and Southeast Asia has led to a higher incidence of DFUs, which require specialized wound care products for effective management and infection prevention.

European wound dressing market was valued at $4,177.7 million in 2025 and is projected to reach $ 6,050.8 million by 2035, growing at a CAGR of 3.9% during the forecast Period (2026-2035). Recent approvals of advanced wound care technologies are accelerating adoption in healthcare facilities, supporting market growth in Europe by enabling more effective management of chronic wounds. These developments reflect the increasing focus on innovations that improve healing outcomes and reduce healthcare burdens. For instance, in September 2025, Convatec received regulatory approval for ConvaMatrix, a porcine placenta-derived skin substitute designed to aid the healing of hard-to-heal wounds such as venous leg ulcers and diabetic foot ulcers.

Germany wound dressing market was valued at $693.6 million in 2025 and is projected to reach $ 1,208.4 million by 2035, growing at a CAGR of 5.8% during the forecast period (2026-2035). As consumers desire aesthetic choices, the demand for discreet wound care solutions, especially invisible dressings, is driving market growth. For instance, in January 2026, Beiersdorf launched new invisible wound care products under its Hansaplast, Elastoplast, and CURITAS Second Skin Protection brands as part of its Health Care growth strategy. This includes a Second Skin Protection Spray Plaster and a Liquid Plaster Concentrate, both creating a flexible, invisible film over minor wounds.

Electronic health records (EHR) market was valued at $26.2 billion in 2025 and is projected to reach $64.5 billion by 2035, growing at a CAGR of 9.5% during the forecast Period (2026-2035).  In Electronic Health Records (EHR) systems, client-based roles primarily involve healthcare providers, hospitals, clinics, and other healthcare organizations that implement and utilize the software to manage patient information. The clients drive system adoption by defining workflows, customizing functionalities, and integrating EHR solutions with existing clinical and administrative processes. The feedback and usage patterns influence product development, feature enhancements, and AI integration within EHR platforms. Clients additionally play a key role in ensuring data accuracy, compliance with regulations, and effective patient engagement. Overall, active participation is essential for maximizing the efficiency, utility, and market growth of EHR systems globally.

Wound dressing market was valued at $15.2 billion in 2025 and is projected to reach $22.5 billion by 2035, growing at a CAGR of 4.1% during the forecast Period (2026-2035).The growing clinical and economic burden associated with long-term wound care is directly influencing the demand for reliable and effective wound management solutions across healthcare settings. As healthcare systems increasingly prioritize early intervention, infection prevention, and improved healing outcomes, the adoption of advanced and traditional wound dressing products continues to expand, positioning chronic wound prevalence as a key growth catalyst for the global wound dressing market.

Indian wound dressing market was valued at $693.6 million in 2025 and is projected to reach $ 1,208.4 million by 2035, growing at a CAGR of 5.8% during the forecast period (2026-2035). India’s rising burden of diabetes has significantly increased the incidence of chronic, slow-healing wounds, particularly diabetic foot ulcers, which often require prolonged and specialized wound management. As a result, the Indian wound dressing market is witnessing a growing shift toward advanced therapeutic dressings that go beyond basic wound coverage to actively support healing, infection control, and tissue regeneration. This evolving clinical need is encouraging the introduction of innovative dressing technologies designed for complex and non-healing wounds.